PET/MRI:脑肿瘤的多参数成像
本文综述了PET/MRI在脑肿瘤多参数成像中的应用,结合弥散加权成像、波谱成像和PET代谢成像评估肿瘤范围与分化程度,指出多参数分析是PET/MRI的天然优势,但存在成本较高和可及性有限的缺点。
要点
- PET/MRI结合形态、微结构和功能成像,可综合评估脑肿瘤组织特性。
- 18F-FET、18F-FDOPA、18F-FCH用于评估肿瘤总体范围。
- 18F-FDG、18F-FLT、18F-FDOPA和18F-FET用于评估肿瘤分化程度。
核心结论
- PET/MRI扫描脑肿瘤是多参数分析组织特征和确定肿瘤表型的天然优势,是神经放射学走向分子水平全面成像的新方向。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告。
关键影像表现/征象
- 弥散加权成像提供组织细胞密度信息。
- 波谱成像可评估神经元完整性、肿瘤缺氧时可能的无氧糖酵解以及细胞膜合成或降解加速。
- PET代谢成像评估主要代谢通路,确定肿瘤总体范围或分化程度。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文指出PET/MRI的缺点是成本较高且在所有拥有神经肿瘤手术的中心可及性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
A combination of morphological imaging of the brain with microstructural and functional imaging provides a comprehensive overview of the properties of individual tissues. While diffusion weighted imaging provides information about tissue cellularity, spectroscopic imaging allows us to evaluate the integrity of neurons and possible anaerobic glycolysis during tumor hypoxia, in addition to the presence of accelerated synthesis or degradation of cellular membranes; on the other hand, PET metabolic imaging is used to evaluate major metabolic pathways, determining the overall extent of the tumor (18F-FET, 18F-FDOPA, 18F-FCH) or the degree of differentiation (18F-FDG, 18F-FLT, 18F-FDOPA and 18F-FET). Multi-parameter analysis of tissue characteristics and determination of the phenotype of the tumor tissue is a natural advantage of PET/MRI scanning. The disadvantages are higher cost and limited availability in all centers with neuro-oncology surgery. PET/MRI scanning of brain tumors is one of the most promising indications since the earliest experiments with integrated PET/MRI imaging systems, and along with hybrid imaging of neurodegenerative diseases, represent a new direction in the development of neuroradiology on the path towards comprehensive imaging at the molecular level.
引用
- Ferda J, Ferdová E, Hes O, et al. PET/MRI: Multiparametric imaging of brain tumors. Eur J Radiol. 2017. PMID: 28283219. doi:10.1016/j.ejrad.2017.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。